Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04281979
NA

Effects of a Specific Substance in Smokers

Sponsor: Oregon Health and Science University

View on ClinicalTrials.gov

Summary

Although rates of cigarette use are declining, the proportion of nondaily smokers is rising, particularly among young adults. Among young adults, nondaily smoking is associated with negative health consequences and, for some, may lead to the establishment of life-long smoking patterns. The goal of this project is to understand the behavioral, psychological and neurobiological factors that contribute to cigarette use in nondaily smokers to aid the development of tailored evidence-based interventions.

Official title: An MRI Study of Neural Activity Following Exposure to a Specific Substance in Young Cigarette Smokers

Key Details

Gender

All

Age Range

21 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2020-02-25

Completion Date

2025-12-31

Last Updated

2025-07-28

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Study Agent

The study agent will be administered via beverages and/or a capsule. The substances used in the study are legal, non-prescription, and are proven safe for human consumption at the doses used. The study agent may be a depressant (such as alcohol), a stimulant (such as caffeine), or an analgesic (such as aspirin).

DRUG

Placebo

In the placebo conditions participants will consume beverages and capsules that contain no or very small quantities of the study agent.

Locations (1)

Oregon Health and Science University

Portland, Oregon, United States